RE: Takatori K, Terashima K, Yoshida R, Horai A, Satake S, Ose T, Kitajima N, Kinoshita Y, Demizu Y, Fuwa N. Upper gastrointestinal complications associated with gemcitabine-concurrent proton radiotherapy for inoperable pancreatic cancer. J Gastroenterol. 2013; (E-pub only)
- PMID: 24294518
- PMCID: PMC3819775
- DOI: 10.3978/j.issn.2078-6891.2013.048
RE: Takatori K, Terashima K, Yoshida R, Horai A, Satake S, Ose T, Kitajima N, Kinoshita Y, Demizu Y, Fuwa N. Upper gastrointestinal complications associated with gemcitabine-concurrent proton radiotherapy for inoperable pancreatic cancer. J Gastroenterol. 2013; (E-pub only)
Similar articles
-
Purification, characterization, and the complete amino acid sequence of porcine pancreatic deoxyribonuclease.J Biol Chem. 1986 Dec 5;261(34):16006-11. J Biol Chem. 1986. PMID: 3782104
-
Large-scale glycomics for discovering cancer-associated N-glycans by integrating glycoblotting and mass spectrometry.Methods Enzymol. 2010;478:109-25. doi: 10.1016/S0076-6879(10)78004-6. Methods Enzymol. 2010. PMID: 20816476
-
Isolation and structures of glycoprotein-derived free oligosaccharides from the unfertilized eggs of Scyliorhinus caniculus. Characterization of the sequences galactose(alpha 1-4)galactose(beta 1-3)-N-acetylglucosamine and N-acetylneuraminic acid(alpha 2-6)galactose(beta 1-3)-N-acetylglucosamine.Eur J Biochem. 1996 Jan 15;235(1-2):199-206. doi: 10.1111/j.1432-1033.1996.00199.x. Eur J Biochem. 1996. PMID: 8631330
-
Functional tissue engineering for ligament healing: potential of antisense gene therapy.Ann Biomed Eng. 2004 Mar;32(3):342-51. doi: 10.1023/b:abme.0000017551.93144.1a. Ann Biomed Eng. 2004. PMID: 15098538 Review.
Cited by
-
Clinical Limitations of Photon, Proton and Carbon Ion Therapy for Pancreatic Cancer.Cancers (Basel). 2020 Jan 9;12(1):163. doi: 10.3390/cancers12010163. Cancers (Basel). 2020. PMID: 31936565 Free PMC article. Review.
-
Effective radiotherapeutic treatment intensification in patients with pancreatic cancer: higher doses alone, higher RBE or both?Radiat Oncol. 2017 Dec 27;12(1):203. doi: 10.1186/s13014-017-0945-2. Radiat Oncol. 2017. PMID: 29282139 Free PMC article. Review.
-
Proton Therapy in the Management of Pancreatic Cancer.Cancers (Basel). 2022 Jun 4;14(11):2789. doi: 10.3390/cancers14112789. Cancers (Basel). 2022. PMID: 35681769 Free PMC article. Review.
-
Proton therapy for pancreatic cancer.World J Gastrointest Oncol. 2015 Sep 15;7(9):141-7. doi: 10.4251/wjgo.v7.i9.141. World J Gastrointest Oncol. 2015. PMID: 26380057 Free PMC article. Review.
References
-
- Takatori K, Terashima K, Yoshida R, et al. Upper gastrointestinal complications associated with gemcitabine-concurrent proton radiotherapy for inoperable pancreatic cancer. J Gastroenterol. 2013 [Epub ahead of print] - PubMed
-
- Nichols RC, Jr, George TJ, Zaiden RA, Jr, et al. Proton therapy with concomitant capecitabine for pancreatic and ampullary cancers is associated with a low incidence of gastrointestinal toxicity. Acta Oncol 2013;52:498-505 - PubMed
-
- Nichols RC, Jr, Huh SN, Prado KL, et al. Protons offer reduced normal-tissue exposure for patients receiving postoperative radiotherapy for resected pancreatic head cancer. Int J Radiat Oncol Biol Phys 2012;83:158-63 - PubMed
LinkOut - more resources
Full Text Sources